Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Resectable Pancreas Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00593866
What this trial is testing

Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Michigan Rogel Cancer Center 50
Early research (Phase 1)Not Yet RecruitingNCT07756281
What this trial is testing

First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Acinar Carcinoma
Synnovation Therapeutics, Inc. 40
Large-scale testing (Phase 3)Ended earlyNCT00031837
What this trial is testing

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerThromboembolism
Gary Morrow 400
Early research (Phase 1)Study completedNCT00761345
What this trial is testing

Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma Non-resectableMetastatic Pancreatic Cancer
Fox Chase Cancer Center 27
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Post-approval studies (Phase 4)Ended earlyNCT01887041
What this trial is testing

Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer

Who this might be right for
Local Tumor SpreadAdvanced CancerMetastasized+2 more
Universitätsklinikum Hamburg-Eppendorf 24
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT05053971
What this trial is testing

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmLocally Advanced Pancreatic CarcinomaMetastatic Pancreatic Carcinoma+6 more
National Cancer Institute (NCI) 49
Testing effectiveness (Phase 2)Temporarily pausedNCT06211933
What this trial is testing

Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS)

Who this might be right for
Non-Resectable Pancreas Carcinoma
Centre Leon Berard 26
Not applicableStudy completedNCT03590275
What this trial is testing

Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX

Who this might be right for
Pancreatic Cancer Non-resectable
Azienda Ospedaliero, Universitaria Pisana 343
Testing effectiveness (Phase 2)Study completedNCT00002689
What this trial is testing

Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Center for Molecular Medicine 48
Not applicableEnded earlyNCT03225781
What this trial is testing

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Universita di Verona 1
Large-scale testing (Phase 3)Study completedNCT01827553
What this trial is testing

Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy

Who this might be right for
Pancreatic Cancer
University of Erlangen-Nürnberg Medical School 830
Not applicableUnknownNCT01665625
What this trial is testing

Regional Versus Systemic Chemotherapy in the Treatment of Unresectable Pancreatic Cancer

Who this might be right for
Unresectable Pancreatic Cancer
Air Force Military Medical University, China 90
Testing effectiveness (Phase 2)Looking for participantsNCT07600268
What this trial is testing

Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Shandong Cancer Hospital and Institute 24
Large-scale testing (Phase 3)Ended earlyNCT01900327
What this trial is testing

Neoadjuvant Treatment in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Universitätsklinikum Hamburg-Eppendorf 32
Not applicableLooking for participantsNCT06937996
What this trial is testing

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-

Who this might be right for
Pancreatic Cancer Non-resectable
Englewood Hospital and Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT03627390
What this trial is testing

BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerUnresectable Pancreatic Cancer
Meabco A/S 16
Testing effectiveness (Phase 2)Study completedNCT00710710
What this trial is testing

Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Boehringer Ingelheim 89
Not applicableLooking for participantsNCT07696572
What this trial is testing

EUS Procedures Using RIVOS™ EUS Access Device

Who this might be right for
Pancreatic Fluid CollectionsBiliary ObstructionPancreatic Duct Obstruction+2 more
Orlando Health, Inc. 30
Next Page